Paclitaxel-induced Hypersensitivity Reaction
An immunological response that results in an adverse reaction due to a certain drug is known as a hypersensitivity reaction (HSR). Such type of reactions is seen with antineoplastic agents. HSR is commonly seen with one of the chemotherapeutic agents, namely, paclitaxel. Occurrence of such reactions...
Saved in:
Main Authors: | Cyril Sajan, Elizabeth Jacob, Varunsingh Saggu, Rajesh Hadia, Hemraj Singh Rajput |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of the Scientific Society |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jss.jss_41_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolocumab-induced delayed skin hypersensitivity reaction in a patient with familial hypercholesterolaemia
by: Grzegorz Porebski, et al.
Published: (2024-02-01) -
Evaluation of the basophil activation in immediate type
hypersensitivity reactions to chemotherapeutic agents
by: Gözde Köycü Buhari, et al.
Published: (2024-02-01) -
Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P‐SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer
by: Yun Bai, et al.
Published: (2025-01-01) -
Case report: Tocilizumab for hypersensitivity reaction after oxaliplatin in a patient with NK/T-cell lymphoma
by: Juanyan Liao, et al.
Published: (2025-01-01) -
Clinical Presentations and Characteristics of NSAIDs Hypersensitivity in a Tertiary Care Hospital in Indonesia: A Case Series
by: Nurmesa A, et al.
Published: (2025-01-01)